Table 1.
Relationships Between YAP Expression and Clinicopathological Features in 68 Patients with GC
| Clinical Parameters | Case No. | YAP Expression | χ2 | P value | |
|---|---|---|---|---|---|
| None or Low | High | ||||
| Total | 68 | 18 (28.9%) | 50 (71.1%) | ||
| Age | |||||
| <65 | 33 | 7 (27.8%) | 26 (72.2%) | 0.911 | 0.34 |
| ≥65 | 35 | 11 (30.0%) | 24 (70.0%) | ||
| Gender | |||||
| Male | 45 | 11 (28.8%) | 34 (71.2%) | 0.281 | 0.596 |
| Female | 23 | 7 (29.6%) | 16 (70.4%) | ||
| Tumor size | |||||
| <5cm | 34 | 10 (44.4%) | 24 (55.6%) | 0.302 | 0.582 |
| ≥5cm | 34 | 8 (30.8%) | 26 (69.2%) | ||
| Tumor location | |||||
| U&M | 41 | 10 (26.7%) | 31 (73.3%) | 0.230 | 0.632 |
| L | 27 | 8 (32.3%) | 19 (67.7%) | ||
| Depth of invasion | |||||
| T1-2 | 17 | 6 (31.8%) | 11 (68.2%) | 0.907 | 0.341 |
| T3-4 | 51 | 12 (34.8%) | 39 (65.2%) | ||
| Lymph node metastasis | |||||
| No | 22 | 11 (52.0%) | 11 (48.0%) | 10.841 | 0.001** |
| Yes | 46 | 6 (17.6%) | 40 (82.4%) | ||
| TNM Stage | |||||
| I/II | 25 | 11 (46.4%) | 14 (53.6%) | 6.242 | 0.012* |
| III/IV | 43 | 7 (18.8%) | 36 (81.2%) | ||
Notes: *P<0.05, **P<0.01.